These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

87 related items for PubMed ID: 2846397

  • 21. Assessment of driving capability through the use of clinical and psychomotor tests in relation to blood cannabinoids levels following oral administration of 20 mg dronabinol or of a cannabis decoction made with 20 or 60 mg Delta9-THC.
    Ménétrey A, Augsburger M, Favrat B, Pin MA, Rothuizen LE, Appenzeller M, Buclin T, Mangin P, Giroud C.
    J Anal Toxicol; 2005; 29(5):327-38. PubMed ID: 16105257
    [Abstract] [Full Text] [Related]

  • 22. Characterization of EP-receptor subtypes involved in allodynia and hyperalgesia induced by intrathecal administration of prostaglandin E2 to mice.
    Minami T, Nishihara I, Uda R, Ito S, Hyodo M, Hayaishi O.
    Br J Pharmacol; 1994 Jul; 112(3):735-40. PubMed ID: 7921597
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Non-cannabinoid CB1, non-cannabinoid CB2 antinociceptive effects of several novel compounds in the PPQ stretch test in mice.
    Haller VL, Cichewicz DL, Welch SP.
    Eur J Pharmacol; 2006 Sep 28; 546(1-3):60-8. PubMed ID: 16919265
    [Abstract] [Full Text] [Related]

  • 27. Analgesic interaction between nitrous oxide and delta-9-tetrahydrocannabinol in the rat.
    Novelli GP, Peduto VA, Bertol E, Mari F, Pieraccioli E.
    Br J Anaesth; 1983 Oct 28; 55(10):997-1000. PubMed ID: 6313026
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Characterization of anandamide- and fluoroanandamide-induced antinociception and cross-tolerance to delta 9-THC after intrathecal administration to mice: blockade of delta 9-THC-induced antinociception.
    Welch SP, Dunlow LD, Patrick GS, Razdan RK.
    J Pharmacol Exp Ther; 1995 Jun 28; 273(3):1235-44. PubMed ID: 7791096
    [Abstract] [Full Text] [Related]

  • 30. Levonantradol: a role for central prostanoid mechanisms?
    Milne GM, Johnson MR.
    J Clin Pharmacol; 1981 Jun 28; 21(S1):367S-374S. PubMed ID: 6271837
    [Abstract] [Full Text] [Related]

  • 31. Modulation of cannabinoid-induced antinociception after intracerebroventricular versus intrathecal administration to mice: possible mechanisms for interaction with morphine.
    Welch SP, Thomas C, Patrick GS.
    J Pharmacol Exp Ther; 1995 Jan 28; 272(1):310-21. PubMed ID: 7815346
    [Abstract] [Full Text] [Related]

  • 32. Conditioned hyperalgesia depends on the pain sensitivity measure.
    Krank MD.
    Behav Neurosci; 1987 Dec 28; 101(6):854-7. PubMed ID: 3426799
    [Abstract] [Full Text] [Related]

  • 33. Tonic analgesic effects of delta 9-tetrahydrocannabinol as measured with the formalin test.
    Moss DE, Johnson RL.
    Eur J Pharmacol; 1980 Feb 08; 61(3):313-5. PubMed ID: 6244965
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Central and peripheral mechanisms contribute to the antiemetic actions of delta-9-tetrahydrocannabinol against 5-hydroxytryptophan-induced emesis.
    Darmani NA, Johnson JC.
    Eur J Pharmacol; 2004 Mar 19; 488(1-3):201-12. PubMed ID: 15044052
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 5.